CTNM Competitors & Alternatives
Compare Contineum Therapeutics, Inc. Class A Common Stock with similar stocks in the same industry
Biotechnology
CTNM
Main Stock$12.99
Tradestie Score
71
Market Cap
$308.74M
Analyst Upside
+70.5%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VSTM
Verastem, Inc.
|
$7.90
|
$541.60M | - | 46 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$10.93
|
$540.97M | - | 48 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$10.18
|
$529.35M | 11.8 | 50 | Compare |
|
MNPR
Monopar Therapeutics Inc. Common Stock
|
$77.97
|
$522.78M | - | 51 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$1.82
|
$512.39M | - | 59 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$46.97
|
$505.12M | 2.9 | 46 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$97.93
|
$492.21M | - | 57 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$40.17
|
$474.20M | 28.2 | 46 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$10.75
|
$468.01M | - | 38 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$11.26
|
$463.20M | - | 39 | Compare |
More CTNM Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry